Product
Alkaline Glucosodiene
1 clinical trial
1 indication
Indication
Triple-Negative Breast CancerClinical trial
Targeting Triple-negative Breast Cancer or ER-positive, PR Positive her2 Negative by Alkaline Glucosodiene Molecules Via a Metabolic Pathway Phase I Clinical TrialStatus: Not yet recruiting, Estimated PCD: 2024-12-31